Skip to main content

Vertex Pharmaceuticals TRIKAFTA/KAFTRIO revenue

  • VRTX · Nasdaq
  • Pharmaceuticals
  • Biotechnology
  • S&P 500
$538.60−0.74%Close 13 Nov 2026

TRIKAFTA/KAFTRIO revenue at Vertex Pharmaceuticals came to $2.4B for the quarter to 30 Sep 2026, down 8.2% from a year earlier.

As Vertex Pharmaceuticals reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 3 Nov 2026.

By quarter

$2.3BDec 2023$2.5BMar 2024$2.4BJun 2024$2.6BSep 2024$2.7BDec 2024$2.5BMar 2025$2.6BJun 2025$2.7BSep 2025$2.6BDec 2025$2.4BMar 2026$2.5BJun 2026$2.4BSep 2026
Vertex Pharmaceuticals TRIKAFTA/KAFTRIO revenue, every reported period
Period endingTRIKAFTA/KAFTRIO revenueChange on a yearFiled
30 Sep 2026$2.4Bdown 8.2%3 Nov 2026
30 Jun 2026$2.5Bdown 2.1%4 Aug 2026
31 Mar 2026$2.4Bdown 7.1%5 May 2026
31 Dec 2025$2.6Bdown 5.5%13 Feb 2026
30 Sep 2025$2.7Bup 2.7%4 Nov 2025
30 Jun 2025$2.6Bup 4.2%5 Aug 2025
31 Mar 2025$2.5Bup 2.1%6 May 2025
31 Dec 2024$2.7Bup 16.6%13 Feb 2025
30 Sep 2024$2.6Bup 13.7%5 Nov 2024
30 Jun 2024$2.4Bup 9.3%2 Aug 2024
31 Mar 2024$2.5Bup 18.5%7 May 2024
31 Dec 2023$2.3Bup 15.4%15 Feb 2024
30 Sep 2023$2.3Bup 13.1%7 Nov 2023
30 Jun 2023$2.2Bup 18.3%2 Aug 2023
31 Mar 2023$2.1Bup 19.0%2 May 2023
31 Dec 2022$2.0Bup 19.4%10 Feb 2023
30 Sep 2022$2.0Bup 29.2%28 Oct 2022
30 Jun 2022$1.9Bup 50.8%5 Aug 2022
31 Mar 2022$1.8Bup 47.6%6 May 2022
31 Dec 2021$1.7Bup 55.2%9 Feb 2022
30 Sep 2021$1.6Bup 62.0%3 Nov 2021
30 Jun 2021$1.3Bup 36.8%30 Jul 2021
31 Mar 2021$1.2Bup 33.3%30 Apr 2021
31 Dec 2020$1.1Bup 159.6%11 Feb 2021
30 Sep 2020$960.3M—30 Oct 2020
30 Jun 2020$917.7M—31 Jul 2020
31 Mar 2020$895.2M—1 May 2020
31 Dec 2019$420.1M—13 Feb 2020
30 Sep 2019$0—31 Oct 2019
30 Jun 2019$0—1 Aug 2019
31 Mar 2019$0—1 May 2019
31 Dec 2018$0—13 Feb 2019
30 Sep 2018$0—25 Oct 2018
30 Jun 2018$0—26 Jul 2018
31 Mar 2018$0down 100.0%27 Apr 2018
31 Mar 2017$46,000—28 Apr 2017

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Vertex Pharmaceuticals: Product revenues, net revenue · ALYFTREK revenue · CASGEVY revenue · JOURNAVX revenue · United States revenue · Europe revenue · financial statements

Every KPI and segment of VRTX, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.